These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 25006736)

  • 21. Multitarget Stool DNA Screening in Clinical Practice: High Positive Predictive Value for Colorectal Neoplasia Regardless of Exposure to Previous Colonoscopy.
    Eckmann JD; Ebner DW; Bering J; Kahn A; Rodriguez E; Devens ME; Lowrie KL; Doering K; Then S; Burger KN; Mahoney DW; Prichard DO; Wallace MB; Gurudu SR; Finney LJ; Limburg P; Berger B; Ahlquist DA; Kisiel JB
    Am J Gastroenterol; 2020 Apr; 115(4):608-615. PubMed ID: 32068535
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stool DNA screening for colorectal neoplasia: biological and technical basis for high detection rates.
    Berger BM; Ahlquist DA
    Pathology; 2012 Feb; 44(2):80-8. PubMed ID: 22198259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specificity of the Multi-Target Stool DNA Test for Colorectal Cancer Screening in Average-Risk 45-49 Year-Olds: A Cross-Sectional Study.
    Imperiale TF; Kisiel JB; Itzkowitz SH; Scheu B; Duimstra EK; Statz S; Berger BM; Limburg PJ
    Cancer Prev Res (Phila); 2021 Apr; 14(4):489-496. PubMed ID: 33436397
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Next-generation stool DNA testing: expanding the scope.
    Ahlquist DA
    Gastroenterology; 2009 Jun; 136(7):2068-73. PubMed ID: 19379748
    [No Abstract]   [Full Text] [Related]  

  • 25. Screening with a fecal multitarget DNA test.
    Young GP; Worthley DL
    Gastroenterology; 2005 Aug; 129(2):757-9; discussion 759. PubMed ID: 16083732
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparative Effectiveness and Cost Effectiveness of a Multitarget Stool DNA Test to Screen for Colorectal Neoplasia.
    Ladabaum U; Mannalithara A
    Gastroenterology; 2016 Sep; 151(3):427-439.e6. PubMed ID: 27311556
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Colorectal Cancer Screening With the Multitarget Stool DNA Test.
    Kisiel JB; Limburg PJ
    Am J Gastroenterol; 2020 Nov; 115(11):1737-1740. PubMed ID: 33156086
    [No Abstract]   [Full Text] [Related]  

  • 28. Stool DNA screening for colorectal cancer: opportunities to improve value with next generation tests.
    Kisiel JB; Ahlquist DA
    J Clin Gastroenterol; 2011 Apr; 45(4):301-8. PubMed ID: 20856138
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term Follow-up of Patients Having False-Positive Multitarget Stool DNA Tests after Negative Screening Colonoscopy: The LONG-HAUL Cohort Study.
    Cotter TG; Burger KN; Devens ME; Simonson JA; Lowrie KL; Heigh RI; Mahoney DW; Johnson DH; Ahlquist DA; Kisiel JB
    Cancer Epidemiol Biomarkers Prev; 2017 Apr; 26(4):614-621. PubMed ID: 27999144
    [No Abstract]   [Full Text] [Related]  

  • 30. Advances in the use of fecal DNA screening for the detection of colorectal cancer.
    Clin Colorectal Cancer; 2003 Feb; 2(4):210-2. PubMed ID: 12620139
    [No Abstract]   [Full Text] [Related]  

  • 31. Stool DNA analysis detects premorphological colorectal neoplasia: a case report.
    Øgreid D; Hamre E
    Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):725-7. PubMed ID: 17625445
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multi-target stool DNA test in the surveillance of inflammatory bowel disease: a cross-sectional cohort study.
    Klepp P; Kisiel JB; Småstuen MC; Røseth A; Andersen SN; Vatn MH; Ahlquist DA; Moum BA; Brackmann S
    Scand J Gastroenterol; 2018 Mar; 53(3):273-278. PubMed ID: 29313389
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening for Colorectal Cancer Using a Multitarget Stool DNA Test: Modeling the Effect of the Intertest Interval on Clinical Effectiveness.
    Berger BM; Schroy PC; Dinh TA
    Clin Colorectal Cancer; 2016 Sep; 15(3):e65-74. PubMed ID: 26792032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular stool testing for the early detection of colorectal cancer: swan song for p53?
    Ferretti G; Felici A; Ciccarese M; Papaldo P; Carlini P; Fabi A; Gelibter A; Cognetti F
    Ann Oncol; 2006 Jun; 17(6):1026. PubMed ID: 16291578
    [No Abstract]   [Full Text] [Related]  

  • 35. Disparities in Rates of Multitarget Stool DNA Test Completion for Colorectal Cancer Screening.
    Dong J; Said H; Miller SJ; Systrom HK; Feuerstein JD
    J Clin Gastroenterol; 2024 Sep; 58(8):805-809. PubMed ID: 38019086
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular markers for colorectal cancer screening.
    Dickinson BT; Kisiel J; Ahlquist DA; Grady WM
    Gut; 2015 Sep; 64(9):1485-94. PubMed ID: 25994221
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Colorectal Cancer Screening: Stool DNA and Other Noninvasive Modalities.
    Bailey JR; Aggarwal A; Imperiale TF
    Gut Liver; 2016 Mar; 10(2):204-11. PubMed ID: 26934885
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stool DNA: a viable option for colorectal cancer screening.
    Hardison DM; Shuber AP
    Gastroenterology; 2005 Dec; 129(6):2128-9; author reply 2129. PubMed ID: 16344091
    [No Abstract]   [Full Text] [Related]  

  • 39. Stool Testing for Colorectal Cancer Screening.
    Robertson DJ; Imperiale TF
    Gastroenterology; 2015 Oct; 149(5):1286-93. PubMed ID: 26033632
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutated DNA in the stool--does it have a role in colorectal cancer screening?
    Half EE; Lynch PM
    Nat Clin Pract Gastroenterol Hepatol; 2006 Nov; 3(11):594-5. PubMed ID: 17068491
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.